Nucific Review: Price, Pros & Cons
Nucific, a supplement brand, also runs a prescription GLP-1 program through OpenLoop Health's licensed providers, with compounded semaglutide from $117 a month, tirzepatide from $139, and brand-name Ozempic and Zepbound.
In this review
Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.
Prices at a glance
- Semaglutide
- $117/moLowest advertised price; plan length and dose not stated, compounded
- Tirzepatide
- $139/moLowest advertised price; plan length and dose not stated, compounded
- Coverage
- Coverage not published
- Brand-name
- Yes
Semaglutide · estimated annual cost
$1,404
Tirzepatide · estimated annual cost
$1,668
Who Nucific may suit
Shoppers who want low advertised prices on compounded semaglutide or tirzepatide, with medication, labs and provider visits in one price and no membership fee.
Where the value is
- Publishes prices up front: compounded semaglutide from $117 a month and tirzepatide from $139, plus lower-dose microdose plans and brand-name Ozempic and Zepbound
- The treatment price includes the medication, required labs and provider consultations, with no membership fee
- Prescribing is done by OpenLoop Health's network of U.S.-licensed providers
- You can cancel at any time to stop future billing
The tradeoffs
- The 'as low as' prices don't say which plan length or dose they belong to, and the sign-up discount applies to the first payment only
- Fees aren't refunded if you cancel mid-cycle, and you must cancel at least 72 hours before your next billing date
- Doesn't name its pharmacies or list the states it serves; its founder, Dr. Amy Lee, MD, is named, but no medical director for the prescribing network is
- The same storefront sells over-the-counter supplements, so make sure you're buying the prescription program
A supplement brand that now prescribes
Nucific sells supplements, including its Bio-X4 line, as well as prescription treatment. Its GLP-1 program is a separate, prescription service with its own support line and email, so don't confuse it with the over-the-counter products on the same storefront.
The program offers six options:
- Compounded semaglutide, as low as $117 a month, and compounded tirzepatide, as low as $139, at standard doses.
- Microdose versions of both, at lower doses for people who want a gradual start, as low as $130 and $150 a month.
- Brand-name Ozempic, listed from $1,498 a month, and Zepbound, from $1,828 a month.
The compounded options are advertised with "as low as" monthly prices, and Nucific doesn't say which plan length or dose those figures belong to. A sign-up discount applies to your first payment only. Before you pay, ask what your first month costs, what later months cost, and whether the price rises with your dose. Compounded medications are not FDA-approved.
Considering Nucific?
Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.
What the price covers
Nucific says the treatment price includes the medication, any lab work your provider requires and your provider consultations, with no separate lab or consultation fees. There's no membership fee. Insurance isn't needed, and HSA or FSA funds can be used for eligible expenses. Shipping in the U.S. is free and the packaging is discreet.
One thing isn't included. If your provider prescribes an anti-nausea medication such as Zofran, it doesn't ship with your GLP-1. You pick it up at your local pharmacy and pay for it there, which Nucific puts at around $12, depending on the pharmacy and your insurance.
Nucific also sells NAD+, sermorelin and a B12 injection, and suggests adding them to a GLP-1 plan. They're priced separately, and none of them is needed for weight-loss treatment.
Who prescribes and who fills it
Nucific doesn't treat patients itself. Clinical care comes from OpenLoop Health and its affiliated networks of U.S.-licensed providers, who review your assessment and decide whether to prescribe, adjust or decline treatment. The assessment takes about three minutes, and Nucific says eligible patients can be approved the same day. After that, you can message your provider as often as you need.
Nucific doesn't make or dispense medication. Prescriptions go to licensed U.S. pharmacies that it doesn't name. Nucific's founder, Dr. Amy Lee, is a physician board-certified in internal medicine, obesity medicine and clinical nutrition. Nucific doesn't list the states it serves, so confirm yours during the assessment.
Refunds and canceling
Nucific's 90-day money-back guarantee is for its supplements. The GLP-1 program has its own billing terms.
Your GLP-1 subscription renews automatically at the interval you choose at sign-up. You can cancel at any time by email or in your account, but the request has to arrive at least 72 hours before your next billing date, or you'll be charged for one more cycle. Fees aren't refunded if you cancel mid-cycle, stop treatment or don't get the results you wanted. If a provider finds you ineligible before treatment begins, you get a full refund for that cycle. Disputes go to individual arbitration.
The Index scorecard
Nucific scored on our six Cost-Efficiency Index factors. See the methodology.
The bottom line
Nucific, a supplement brand, also runs a prescription GLP-1 program through OpenLoop Health's licensed providers, with compounded semaglutide from $117 a month, tirzepatide from $139, and brand-name Ozempic and Zepbound.
Compare the total cost of other GLP-1 programs and alternatives to Nucific before deciding. A clinician should help you choose the right treatment.
Other programs to compare with Nucific
These are partners: we may earn a commission if you sign up, at no cost to you.
LttlPartner
Semaglutide modeled $107.25/mo · Tirzepatide modeled $161.42/mo
Lttl charges $99 every four weeks for compounded semaglutide and $149 for tirzepatide on a cancel-anytime auto-refill, with small discounts for longer supplies.
CoreAge RxPartner
Semaglutide modeled $99/mo · Tirzepatide modeled $149/mo
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
EdenPartner
Semaglutide modeled $99/mo · Tirzepatide modeled $129/mo
Eden charges $99 a month for compounded semaglutide and $129 for compounded tirzepatide, the same at every dose, with the visit, medication and shipping included.
Compare with other providers
The providers whose Cost-Efficiency Index scores sit closest to Nucific's. See the alternatives to Nucific.
- Vital Edge— Vital Edge lists a flat $350 a month for compounded semaglutide and $450 for tirzepatide, plus brand Ozempic, Wegovy, Mounjaro and Rybelsus, but publishes no cancellation or refund terms.66/100
- LifeVine Wellness— LifeVine Wellness lists compounded semaglutide from $247 and tirzepatide from $347 a month, but a footnote says those are monthly equivalents of multi-month plans, and the actual price is set after a provider reviews you.66/100
- iPharma Pharmacy— iPharma Pharmacy, a Houston compounding pharmacy, runs its own online visits and sells compounded semaglutide with glycine at $165 and tirzepatide with glycine at $249, the same price at every dose.66/100
- MyDrHank— Every price this site advertises is a twelve-month prepay rate — its price display returns the cheapest term by design — so the real month-to-month cost is $249-$349, not the "from $171" on the page.65/100
- Collective— Collective sells compounded semaglutide at $59 and tirzepatide at $69 a month, both genuinely medication prices, on top of a $199 annual membership that is required, auto-renewing and not refundable.65/100
- Primary Clinic (Direct GLP)— A Direct Primary Care membership rather than a GLP-1 storefront: $85 semaglutide and $133 tirzepatide sit on top of an $89/mo membership the FAQ says does not include the drug.65/100
Pricing, states and verification reflect Nucific's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Nucific's site. Not medical advice; see our disclosure.